Related Experiment Videos

Altered plasma membrane ultrastructure in multidrug-resistant cells

A L Arsenault1, V Ling, N Kartner

  • 1Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada.

Insights

Multidrug resistance in cancer cells involves changes in plasma membrane structure, not just P-glycoprotein pumps. Freeze-fracture studies reveal increased particle density in resistant cells, suggesting altered membrane architecture.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Multidrug resistance (MDR) is a major challenge in cancer therapy.
  • P-glycoprotein (P-gp) is a known mediator of MDR, acting as a drug efflux pump.
  • The current P-gp model does not fully explain the pleiotropic nature of MDR.

Purpose of the Study:

  • To investigate the structural changes in the plasma membrane associated with multidrug resistance.
  • To determine if MDR induces global alterations in membrane architecture beyond P-gp function.

Main Methods:

  • Utilized freeze-fracture electron microscopy to analyze plasma membrane structure.
  • Compared membrane intramembrane particle (IMP) densities in drug-resistant and drug-sensitive cell lines.
  • Examined IMP densities in a revertant cell line that lost MDR characteristics.

Main Results:

  • Multidrug-resistant Chinese hamster ovary (CHO) and human leukemic cells showed increased IMP densities.
  • A revertant CHO cell line, which lost its MDR phenotype, exhibited IMP densities similar to drug-sensitive cells.
  • These findings indicate a correlation between MDR and altered plasma membrane architecture.

Conclusions:

  • MDR is associated with significant changes in plasma membrane structure, specifically increased IMP density.
  • These structural alterations suggest a broader role for membrane architecture in the MDR phenotype.
  • The findings challenge the sole reliance on the P-gp efflux pump model and highlight the importance of membrane dynamics in MDR.

Related Concept Videos